ARTICLE | Company News
B. Twelve Inc., Medarex deal
January 29, 2001 8:00 AM UTC
The companies will develop and market cancer therapeutics using MEDX's UltiMAb Human Antibody Development System and B. Twelve's vitamin B12 related targets. B. Twelve will have development and market...